Pharmacology
Asthma & COPD inhalers — stepwise therapy
Pharmacology

Asthma & COPD inhalers — stepwise therapy

SABA, ICS, LABA, LAMA, biologics — when each gets added.

Select any text to highlight it or make a flashcard.

Asthma stepwise (GINA-ish)

  • Step 1: low-dose ICS + formoterol PRN (preferred to SABA-only)
  • Step 2: daily low-dose ICS + SABA or ICS/formoterol PRN
  • Step 3: low-dose ICS-LABA (formoterol or salmeterol) + SABA
  • Step 4: medium-dose ICS-LABA
  • Step 5: high-dose ICS-LABA + LAMA (tiotropium) + consider biologic
  • Biologics: omalizumab (anti-IgE — allergic asthma), mepolizumab/benralizumab (anti-IL-5 — eosinophilic), dupilumab (anti-IL-4/13 — type 2 inflammation)

COPD stepwise (GOLD)

  • Group A (low risk, few sx): SABA or SAMA PRN
  • Group B (low risk, more sx): LABA or LAMA
  • Group E (high risk regardless): LABA + LAMA; add ICS if eos ≥ 300 or frequent exacerbations
  • DON'T use ICS monotherapy in COPD (no benefit, increased pneumonia risk)
  • Roflumilast for severe COPD with chronic bronchitis + frequent exacerbations
  • Pulmonary rehab + smoking cessation + vaccines (influenza, pneumococcal, COVID) — biggest non-drug interventions

Acute exacerbations

  • Asthma exacerbation: O2, nebulized albuterol + ipratropium, systemic steroids (PO if mild–moderate, IV if severe), IV magnesium if severe
  • Asthma escalation: BiPAP if respiratory failure; intubate if AMS, exhaustion, hypercapnia worsening
  • COPD exacerbation: O2 (target SpO2 88–92%), bronchodilators, steroids (prednisone 40 mg × 5 days), antibiotics (if purulent sputum, increased dyspnea, mechanical ventilation)
  • COPD severe: BiPAP if pH < 7.35 with hypercapnia and respiratory acidosis (decreases intubation rate)

Side effects

  • SABA (albuterol): tachycardia, tremor, hypokalemia, hyperglycemia
  • LAMA (tiotropium): dry mouth, urinary retention (caution in BPH); paradoxical bronchospasm
  • ICS: oral candidiasis (rinse mouth), dysphonia, ↑ pneumonia in COPD, growth velocity slightly slowed in kids (catches up)
  • Theophylline (rare use): narrow therapeutic index, arrhythmia, seizures, GI

High-yield pearls

  • Asthma + β-blocker → use cardioselective only (or avoid); non-selective can trigger bronchospasm
  • Asthma + aspirin sensitivity + nasal polyps = Samter's triad → use leukotriene modifier (montelukast) or biologics
  • COPD goal O2 sat 88–92% (avoid V/Q mismatch and CO2 retention)
  • BiPAP saves intubation in COPD exacerbation with hypercapnic respiratory acidosis (pH < 7.35)
  • ICS in COPD only when eosinophils ≥ 300 or frequent exacerbations on dual bronchodilator
Quick check

5-question quiz on this note

Test yourself before moving on. ~1 min.

Done reading?
Track your progress by marking this complete.